(Q39664977)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

13 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy (English)

1 reference

13 September 2017

1 reference

Manasi Das

1

1 reference

13 September 2017

Sanjeeb K Sahoo

series ordinal

2

1 reference

13 September 2017

publication date

19 August 2010

1 reference

13 September 2017

1 reference

13 September 2017

volume

7

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

355-369

1 reference

Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles

13 September 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Folate-conjugated polymer micelles for active targeting to cancer cells: preparation, in vitro evaluation of targeting ability and cytotoxicity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Mdm-2: "big brother" of p53.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Structure-based design of potent non-peptide MDM2 inhibitors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Live or let die: the cell's response to p53

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

PUMA, a novel proapoptotic gene, is induced by p53

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Targeted delivery of doxorubicin using stealth liposomes modified with transferrin

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

14-3-3sigma is a p53-regulated inhibitor of G2/M progression

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Polymeric nanoparticles for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Nanotech approaches to drug delivery and imaging

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Molecular characterization of the hdm2-p53 interaction

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Apoptotic signaling by c-MYC.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Ligand-based targeted therapy for cancer tissue

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

MDM2 inhibitors for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

The association of increased lung resistance protein expression with acquired etoposide resistance in human H460 lung cancer cell lines

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Biodegradable nanoparticles for drug and gene delivery to cells and tissue

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Inhibition of apoptosis through localized delivery of rapamycin-loaded nanoparticles prevented neointimal hyperplasia and reendothelialized injured artery

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

p53 Activation by small molecules: application in oncology

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Sentinel lymph node biopsy in breast cancer using technetium-99m tin colloids of different sizes.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Tumor suppressive functions of p53

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

EpCAM-targeted delivery of nanocomplexed siRNA to tumor cells with designed ankyrin repeat proteins

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Identifiers

DOI

10.1016/J.ACTBIO.2010.08.010

1 reference

13 September 2017

1 reference